AngioDynamics, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ANGO Nasdaq 3841 http://www.angiodynamics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AngioDynamics, Inc.

AngioDynamics moving 125 employees into downtown Glens Falls - Jun 6th, 2019 4:00 am
AngioDynamics Divests NAMIC Portfolio to Medline Industries - Jun 5th, 2019 8:05 am
AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference - Jun 4th, 2019 2:01 pm
AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc. - Jun 3rd, 2019 2:01 pm
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange - May 28th, 2019 6:00 am
AngioDynamics IDE Application for NanoKnife Gets FDA Nod - May 23rd, 2019 5:33 am
AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer - May 22nd, 2019 6:00 am
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer - May 13th, 2019 6:00 am
Here’s What Hedge Funds Think About AngioDynamics, Inc. (ANGO) - May 9th, 2019 9:27 am
Why Is AngioDynamics (ANGO) Down 12.1% Since Last Earnings Report? - May 2nd, 2019 7:30 am
The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio - Apr 18th, 2019 5:42 am
AngioDynamics will sell Namic business for $167.5 million - Apr 17th, 2019 5:37 pm
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million - Apr 17th, 2019 2:05 pm
Why AngioDynamics, Inc.’s (NASDAQ:ANGO) Return On Capital Employed Might Be A Concern - Apr 17th, 2019 10:13 am
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer - Apr 17th, 2019 6:01 am
Edited Transcript of ANGO earnings conference call or presentation 2-Apr-19 12:00pm GMT - Apr 10th, 2019 6:57 am
AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates - Apr 3rd, 2019 8:32 am
AngioDynamics (ANGO) Q3 2019 Earnings Conference Call Transcript - Apr 2nd, 2019 6:45 pm
AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study - Apr 2nd, 2019 8:20 am
AngioDynamics (ANGO) Lags Q3 Earnings and Revenue Estimates - Apr 2nd, 2019 6:15 am